Dr. Vetto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-5501
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1984 - 1989
- Brigham and Women's HospitalResidency, Surgery, 1982 - 1984
- Oregon Health and Science University School of MedicineClass of 1982
Certifications & Licensure
- OR State Medical License 1991 - 2025
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Join now to see all
Clinical Trials
- S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma Start of enrollment: 2000 Aug 01
- OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer Start of enrollment: 2005 Apr 01
Publications & Presentations
PubMed
- 170 citationsClinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin MelanomaDale Han, Jonathan S. Zager, Yu Shyr, Heidi Chen, Lynne D. Berry
Journal of Clinical Oncology. 2013-12-10 - 8 citationsNonvisualized sentinel lymph nodes on lymphoscintigraphy in melanoma: predictive factors and surgical outcomes.Darryl Schuitevoerder, Lisa Grinlington, Jeffrey S. Stevens, Robert Nance, Jeanine Fortino
Nuclear Medicine Communications. 2017-05-01 - 13 citationsUsefulness of preoperative lymphoscintigraphy for the identification of sentinel lymph nodes in melanoma.Katherine T. Morris, Jeffrey S. Stevens, Rodney F. Pommier, William S. Fletcher, John T. Vetto
American Journal of Surgery. 2001-05-01
Journal Articles
- Microsatellitosis in Patients with MelanomaRichard L White, Mark B Faries, Stanley P Leong, Andrew J Sinnamon, Dale Han, Jane L Messina, Barbara A Pockaj, Giorgos C Karakousis, Edmund K Bartlett, John T Vetto, ..., Annals of Surgical Oncology
Press Mentions
- Castle Biosciences Announces Publication of Prospective Multicenter Study Demonstrating That Its DecisionDx-Melanoma Test Can Inform Sentinel Lymph Node Biopsy DecisionsJanuary 30th, 2019
- Castle Biosciences’ DecisionDx-Melanoma Test Identifies High-Risk Melanoma Patients Among Those Traditionally Staged as Low Risk in Newly Published StudyJanuary 7th, 2019
- Independent Study Demonstrates Significant and Risk-Appropriate Clinical Impact of DecisionDx-Melanoma Test Results on Patient Management Decisions in MelanomaMarch 21st, 2018
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: